US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist

13.0893
-0.0007-0.01%

Trading May 15 12:29 ET

59.71MMarket Cap-2517P/E (TTM)

Cidara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

-0.84%63.91M

69.41%17.58M

-68.79%12.72M

22.49%7.61M

265.59%25.99M

30.01%64.45M

43.65%10.38M

475.81%40.74M

-81.09%6.22M

195.22%7.11M

Operating revenue

-0.84%63.91M

69.41%17.58M

-68.79%12.72M

22.49%7.61M

265.59%25.99M

30.01%64.45M

43.65%10.38M

475.81%40.74M

-81.09%6.22M

195.22%7.11M

Cost of revenue

1.52M

1.14M

387K

Gross profit

-3.21%62.38M

58.46%16.45M

-69.74%12.33M

64.45M

10.38M

40.74M

Operating expense

-11.32%86.87M

-17.90%22.52M

-19.11%20.89M

5.77%20.45M

-9.29%23.01M

6.67%97.95M

14.32%27.43M

2.82%25.82M

-12.50%19.33M

22.98%25.37M

Selling and administrative expenses

-10.77%18.33M

30.63%7.17M

-38.48%3.56M

-18.75%3.31M

-17.41%4.3M

9.64%20.55M

10.16%5.49M

25.46%5.78M

-6.77%4.07M

8.85%5.2M

-General and administrative expense

-10.77%18.33M

30.63%7.17M

-38.48%3.56M

-18.75%3.31M

-17.41%4.3M

9.64%20.55M

10.16%5.49M

25.46%5.78M

-6.77%4.07M

8.85%5.2M

Research and development costs

-11.46%68.53M

-30.04%15.35M

-13.53%17.33M

12.32%17.14M

-7.20%18.72M

5.91%77.41M

15.41%21.94M

-2.26%20.04M

-13.91%15.26M

27.24%20.17M

Operating profit

26.92%-24.48M

64.38%-6.07M

-157.33%-8.56M

2.15%-12.83M

116.30%2.98M

20.71%-33.5M

-1.68%-17.05M

182.74%14.92M

-221.72%-13.11M

-0.21%-18.26M

Net non-operating interest income expense

944.50%2M

225.31%527K

1,014.55%613K

10,483.33%623K

1,260.00%232K

190.09%191K

590.91%162K

217.02%55K

90.32%-6K

71.43%-20K

Non-operating interest income

944.50%2M

225.31%527K

1,014.55%613K

----

--191K

--162K

--55K

----

Total other finance cost

----

-10,483.33%-623K

-1,260.00%-232K

----

--6K

--20K

Other net income (expense)

Income before tax

32.49%-22.49M

67.16%-5.55M

-153.02%-7.94M

6.94%-12.21M

117.55%3.21M

21.56%-33.31M

-0.52%-16.89M

182.83%14.98M

-222.48%-13.12M

0.06%-18.28M

Income tax

62.87%443K

-76.47%64K

230K

149K

272K

Net income

31.72%-22.93M

67.31%-5.61M

-154.56%-8.17M

5.81%-12.36M

117.55%3.21M

20.92%-33.58M

-2.14%-17.16M

182.83%14.98M

-222.48%-13.12M

0.06%-18.28M

Net income continuous Operations

31.72%-22.93M

67.31%-5.61M

-154.56%-8.17M

5.81%-12.36M

117.55%3.21M

20.92%-33.58M

-2.14%-17.16M

182.83%14.98M

-222.48%-13.12M

0.06%-18.28M

Minority interest income

Net income attributable to the parent company

31.72%-22.93M

67.31%-5.61M

-154.56%-8.17M

5.81%-12.36M

117.55%3.21M

20.92%-33.58M

-2.14%-17.16M

182.83%14.98M

-222.48%-13.12M

0.06%-18.28M

Preferred stock dividends

Other preferred stock dividends

677K

3.08M

Net income attributable to common stockholders

31.72%-22.93M

67.31%-5.61M

-168.69%-8.17M

5.81%-12.36M

113.85%2.53M

20.92%-33.58M

-2.14%-17.16M

165.79%11.9M

-248.76%-13.12M

0.06%-18.28M

Basic earnings per share

45.83%-5.2

68.42%-1.2

-152.94%-1.8

26.32%-2.8

111.11%0.6

40.74%-9.6

26.92%-3.8

145.95%3.4

-205.56%-3.8

30.77%-5.4

Diluted earnings per share

45.83%-5.2

68.42%-1.2

-152.94%-1.8

26.32%-2.8

111.11%0.6

40.74%-9.6

26.92%-3.8

145.95%3.4

-205.56%-3.8

30.77%-5.4

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	-0.84%63.91M	69.41%17.58M	-68.79%12.72M	22.49%7.61M	265.59%25.99M	30.01%64.45M	43.65%10.38M	475.81%40.74M	-81.09%6.22M	195.22%7.11M
Operating revenue	-0.84%63.91M	69.41%17.58M	-68.79%12.72M	22.49%7.61M	265.59%25.99M	30.01%64.45M	43.65%10.38M	475.81%40.74M	-81.09%6.22M	195.22%7.11M
Cost of revenue	1.52M	1.14M	387K			0	0	0
Gross profit	-3.21%62.38M	58.46%16.45M	-69.74%12.33M			64.45M	10.38M	40.74M
Operating expense	-11.32%86.87M	-17.90%22.52M	-19.11%20.89M	5.77%20.45M	-9.29%23.01M	6.67%97.95M	14.32%27.43M	2.82%25.82M	-12.50%19.33M	22.98%25.37M
Selling and administrative expenses	-10.77%18.33M	30.63%7.17M	-38.48%3.56M	-18.75%3.31M	-17.41%4.3M	9.64%20.55M	10.16%5.49M	25.46%5.78M	-6.77%4.07M	8.85%5.2M
-General and administrative expense	-10.77%18.33M	30.63%7.17M	-38.48%3.56M	-18.75%3.31M	-17.41%4.3M	9.64%20.55M	10.16%5.49M	25.46%5.78M	-6.77%4.07M	8.85%5.2M
Research and development costs	-11.46%68.53M	-30.04%15.35M	-13.53%17.33M	12.32%17.14M	-7.20%18.72M	5.91%77.41M	15.41%21.94M	-2.26%20.04M	-13.91%15.26M	27.24%20.17M
Operating profit	26.92%-24.48M	64.38%-6.07M	-157.33%-8.56M	2.15%-12.83M	116.30%2.98M	20.71%-33.5M	-1.68%-17.05M	182.74%14.92M	-221.72%-13.11M	-0.21%-18.26M
Net non-operating interest income expense	944.50%2M	225.31%527K	1,014.55%613K	10,483.33%623K	1,260.00%232K	190.09%191K	590.91%162K	217.02%55K	90.32%-6K	71.43%-20K
Non-operating interest income	944.50%2M	225.31%527K	1,014.55%613K	----	----	--191K	--162K	--55K	----	----
Total other finance cost	----	----	----	-10,483.33%-623K	-1,260.00%-232K	----	----	----	--6K	--20K
Other net income (expense)
Income before tax	32.49%-22.49M	67.16%-5.55M	-153.02%-7.94M	6.94%-12.21M	117.55%3.21M	21.56%-33.31M	-0.52%-16.89M	182.83%14.98M	-222.48%-13.12M	0.06%-18.28M
Income tax	62.87%443K	-76.47%64K	230K	149K		272K	272K	0	0
Net income	31.72%-22.93M	67.31%-5.61M	-154.56%-8.17M	5.81%-12.36M	117.55%3.21M	20.92%-33.58M	-2.14%-17.16M	182.83%14.98M	-222.48%-13.12M	0.06%-18.28M
Net income continuous Operations	31.72%-22.93M	67.31%-5.61M	-154.56%-8.17M	5.81%-12.36M	117.55%3.21M	20.92%-33.58M	-2.14%-17.16M	182.83%14.98M	-222.48%-13.12M	0.06%-18.28M
Minority interest income
Net income attributable to the parent company	31.72%-22.93M	67.31%-5.61M	-154.56%-8.17M	5.81%-12.36M	117.55%3.21M	20.92%-33.58M	-2.14%-17.16M	182.83%14.98M	-222.48%-13.12M	0.06%-18.28M
Preferred stock dividends
Other preferred stock dividends			0		677K			3.08M		0
Net income attributable to common stockholders	31.72%-22.93M	67.31%-5.61M	-168.69%-8.17M	5.81%-12.36M	113.85%2.53M	20.92%-33.58M	-2.14%-17.16M	165.79%11.9M	-248.76%-13.12M	0.06%-18.28M
Basic earnings per share	45.83%-5.2	68.42%-1.2	-152.94%-1.8	26.32%-2.8	111.11%0.6	40.74%-9.6	26.92%-3.8	145.95%3.4	-205.56%-3.8	30.77%-5.4
Diluted earnings per share	45.83%-5.2	68.42%-1.2	-152.94%-1.8	26.32%-2.8	111.11%0.6	40.74%-9.6	26.92%-3.8	145.95%3.4	-205.56%-3.8	30.77%-5.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall